Concepedia

Publication | Open Access

PARPBP is a prognostic marker and confers anthracycline resistance to breast cancer

DOIFull Paper Access

29

Citations

35

References

2020

Year

Bo Chen, Jianguo Lai, Danian Dai, Rong Chen, Ning Liao, Guanfeng Gao, Hailin Tang
Therapeutic Advances in Medical Oncology

Abstract

Taken together, our results highlight that PARPBP is a prognostic marker and confers anthracycline resistance on breast cancer.

References

YearCitations

Page 1